AC Immune SA annual operating margin
2015
2016
2017
2018
2019
2020
2022
2023
2024
2025
AC Immune SA's operating margin was −1,940.05% for fiscal 2025.
View full AC Immune SA company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,940.05% | −1748.25 pp |
| 2024 | 2024-12-31 | −191.80% | +170.50 pp |
| 2023 | 2023-12-31 | −362.30% | +1438.13 pp |
| 2022 | 2022-12-31 | −1,800.43% | −1403.44 pp |
| 2020 | 2020-12-31 | −396.99% | −437.31 pp |
| 2019 | 2019-12-31 | 40.32% | +757.19 pp |
| 2018 | 2018-12-31 | −716.87% | −605.59 pp |
| 2017 | 2017-12-31 | −111.28% | −66.23 pp |
| 2016 | 2016-12-31 | −45.04% | −92.69 pp |
| 2015 | 2015-12-31 | 47.64% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | −1,484.53% | — |
| Q2 2024 | 2024-06-30 | −3,051.09% | — |
| Q3 2022 | 2022-09-30 | −342.22% | — |
Over the last five reported fiscal years, AC Immune SA's operating margin decreased from 40.32% to −1,940.05%, a change of −1980.37 percentage points. The latest reported quarter, Q2 2025, shows −1,484.53%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AC Immune SA filings at SEC.gov ↗